Profile
Helping patients across multiple diseasesRevenue from across therapeutic area with pharma and biotech customers
Solutions for projects and commercial products“Start here – stay here”
1 Approximate splits as per 30 June 2022.
Business modelProviding expert knowledge for peptide-based API's across the entire value chain
API – Active Pharmaceutical Ingredient; CMC – Chemistry, Manufacuring & Controls; GMP – Good Manufacturing Practice; ICH – International Council for Harmonization; LCM – Life Cycle Management; NDA – New Drug Application; PPQ – Process Performance Qualification.
Integrated strategyStriving to be the preferred long-term partner for customers
Footprint with customer proximitySix GMP-certified sites on three continents1
1 Data based on headcount as of 30 June 2022.
Team with solid scientific backgroundHealthy mix of experience
1 Data based on headcount as of 30 June 2022.
Striving for profitable growth1Building on favorable market trends
1 For a reconciliation to the nearest IFRS line item, please refer to the section “Definitions and reconciliations” of this report.